Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: Post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial

Stroke

Volumn 41, Issue 8, 2010, Pages 1841-1844

  Wong, George K C ^a   Poon, Wai S ^a   Chan, Matthew T V ^a   Boet, Ronald ^b   Gin, Tony ^a   Ng, Stephanie C P ^a   Zee, Benny C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b St George's Hospital   (New Zealand)

Author keywords

aneurysm; clinical vasospasm; delayed ischemic neurological deficit; magnesium; subarachnoid hemorrhage

Indexed keywords

MAGNESIUM SULFATE; PLACEBO;

ADULT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LOGISTIC MODELS; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 77955173571     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.585232     Document Type: Article

References (11)

1. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulphate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33-39.
2. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery. 2006;58:1054-1065.
3. van den Bergh WM, on behalf of the MASH Study Group. Magnesium sulphate in aneurysmal subarachnoid hemorrhage. Stroke. 2005;36: 1011-1015.
4. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD. Magnesium sulphate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;96: 510-514.
5. Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulphate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol. 2006;18:142-148.
6. Wong GK, Poon WS, Boet R, Chan MT, Gin T, Ng SC, Zee B, IMASH investigators. Intravenous magnesium sulphate after aneurysmal subarachnoid hemorrhage: a multi-center phase III study. Stroke. 2010;41: 921-926.
7. van den Bergh WM. Magnesium in subarachnoid haemorrhage: proven beneficial? Magnesium Research. 2009;22:121-126.
8. Dorhout Mees SM, van den Bergh WM, Algae A, Rinkel GJ. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:729-731.
9. Helpern JA, Vande Linde AM, Welch KM, Levine SR, Schultz LR, Ordidge RJ, Halvorson HR, Hugg JW. Acute elevation and recovery of intracellular [Mg2 +] following human focal cerebral ischemia. Neurology. 1993;43:1577-1581.
10. van den Bergh WM, Algae A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:276-282.
11. Wong GK, WongR, Mok VC, FanDS, Leung G, Wong A, Chan AS, Zhu CX, Poon WS. Clinical study on cognitive dysfunction after spontaneous subarachnoid hemorrhage: patient profiles and relationship to cholinergic dysfunction. Acta Neurochir. 2009;151:1601-1607.